Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20161207031288N2Phase 3Completed
Phase 3, randomised, single-blind trial of tretinoin in acne vulgaris (2 arms), sponsored by Jarfandishan Navid Salamat. Primary endpoint: Improvement in acne severity by Global Acne Grading System at week 8. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20161207031288N2.